Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Net Margin of 27.42% in Q1 2026, up 61.44% quarter-over-quarter from 16.99% in Q4 2025, and up 3767.0% on a YoY basis from 0.71% in Q1 2025.
Jazz Pharmaceuticals (JAZZ) Net Margin (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Net Margin history runs 16 years deep, the most recent figure standing at 27.42% for Q1 2026.
- In Q1 2026, Net Margin rose 3767.0% year-over-year to 27.42%; the TTM figure through Mar 2026 stood at 0.67% (down 1122.0% YoY), while the FY2025 annual figure was 8.33%, down 2214.0% from the prior year.
- Net Margin was 27.42% for Q1 2026 at Jazz Pharmaceuticals, up from 16.99% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 27.42% in Q1 2026 to a low of 68.7% in Q2 2025.
- Historically, Net Margin has averaged 3.67% across 5 years, with a median of 9.35% in 2023.
- The sharpest annual moves came in 2022 and 2025: Net Margin soared 5248 bps in 2022, then sank 8516 bps in 2025.
- A 5-year view of Net Margin shows it stood at 24.68% in 2022, then surged by 138 bps to 9.35% in 2023, then soared by 88 bps to 17.56% in 2024, then decreased by 3 bps to 16.99% in 2025, then surged by 61 bps to 27.42% in 2026.
- The last three Net Margin figures came in at 27.42% (Q1 2026), 16.99% (Q4 2025), and 22.33% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn | 27.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.42% |
| Dec 31, 2025 | 16.99% |
| Sep 30, 2025 | 22.33% |
| Jun 30, 2025 | -68.70% |
| Mar 31, 2025 | -10.25% |
| Dec 31, 2024 | 17.56% |
| Sep 30, 2024 | 20.41% |
| Jun 30, 2024 | 16.47% |
| Mar 31, 2024 | -1.47% |
| Dec 31, 2023 | 9.35% |
| Sep 30, 2023 | 15.09% |
| Jun 30, 2023 | 11.08% |
| Mar 31, 2023 | 7.89% |
| Dec 31, 2022 | -24.68% |
| Sep 30, 2022 | -1.82% |
| Jun 30, 2022 | 3.98% |
| Mar 31, 2022 | 0.72% |
| Dec 31, 2021 | -3.61% |
| Sep 30, 2021 | -5.92% |
| Jun 30, 2021 | -48.50% |